Sanner launches senior-friendly closure for effervescent packaging
The new FOG 27 closure can be opened in about a third of the time — and with 70% less physical effort compared with conventional closures.
Sanner has developed a new closure for effervescent packaging. Participants of a comparative study confirm that the new FOG 27 closure can be opened in about a third of the time — and with 70% less physical effort compared with conventional closures. Food supplement producers gain satisfied customers and accordingly high repurchase rates.
About a quarter of adults consume nutritional supplements such as vitamins or minerals, often sold as effervescent tablets. About half of these consumers are 60 years or older. According to the German Federal Association of Senior Citizens‘ Organizations (BAGSO), more than 90% of senior citizens struggle with opening consumer packaging in general; three quarters criticize the handling properties of opening mechanisms in particular.
Subsequently, good and easy handling of the packaging is especially important. “For producers of food supplements this is a decisive factor,” says Ursula Hahn, product manager at Sanner. “In case of bad experiences with the packaging, repurchase rates decline considerably.” To find a remedy, Sanner has developed the new, user-friendly FOG 27 closure — and let consumers judge in a comprehensive study.
FOG 27 convinces in consumer test
The test, conducted by the market research institutes Quo Vadis and Packaging Intelligence, focused on the way of opening, as well as the time and physical effort required. The quantitative handling test surveyed 120 women (60%) and men (40%) in charge of their respective households, who purchase and consume vitamin, mineral or painkiller tablets two to three times per month.
The most striking result of the test is that 87% of the participants confirmed the intuitive opening. Apart from the easy removal of the warranty band, testers particularly appreciated the painless, single-handed opening. They neither complained about pressure marks on their thumb, nor about aching fingers. As far as opening time is concerned, the new FOG 27 also stands out from conventional closures: participants required approximately a third of the time to open the FOG 27 (9.2 instead of 25.8 seconds). Moreover, the amount of physical effort needed for the first opening is significantly lower: 12 newton instead of 36 newton.
Reliable product protection, higher convenience
In terms of tightness, the FOG 27 is just as reliable as conventional closures: despite the easy opening, full product protection is ensured. “One of the reasons,” Ursula Hahn explains, "is that the FlipTop of the new closure is tightly attached to the tube and can be intuitively closed.” Another advantage: the closure cannot get lost. This way, a small packaging optimization provides significantly higher convenience and customer satisfaction. Thanks to the good handling, around 90% of best-agers would buy the product with the user-friendly FOG 27 closure again.
Together with the Brilliance Tubes from Sanner, which are decorated using in-mold labelling (IML) technology, customers receive an all-in-one solution for highest convenience and attention at point-of-sale. The Brilliance Tubes offer high-quality, photorealistic printing with endless design varieties. The font size can be flexibly adapted to improve readability. Especially expressive motifs attract customers’ attention; sales messages can be conveyed without many words.
Satisfied customers — high repurchase rates
Ursula Hahn is convinced that "who wants to achieve long-term customer loyalty cannot escape this trend.” Whether as single closure or combined with the Brilliance Tube, the FOG 27 provides several solutions in one: “customers receive a user-friendly packaging; and food supplement producers obtain an especially attractive solution, satisfied customers, and higher repurchase rates,” Hahn concludes.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance